1. Home
  2. CADL vs SHMD Comparison

CADL vs SHMD Comparison

Compare CADL & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$5.10

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

HOLD

Current Price

$5.67

Market Cap

301.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
SHMD
Founded
1999
1864
Country
United States
Germany
Employees
N/A
676
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
357.4M
301.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CADL
SHMD
Price
$5.10
$5.67
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.1M
605.3K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$2.00
52 Week High
$7.24
$10.65

Technical Indicators

Market Signals
Indicator
CADL
SHMD
Relative Strength Index (RSI) 52.99 45.81
Support Level $4.57 $2.33
Resistance Level $5.25 $6.70
Average True Range (ATR) 0.23 0.75
MACD 0.03 0.06
Stochastic Oscillator 84.97 32.11

Price Performance

Historical Comparison
CADL
SHMD

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: